Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Wall Street Has Written Off AMC Stock. Here′s Why That′s a Mistake. (Fool) +++ AMC ENTERTAINMENT Aktie -4,08%

NEOGEN Aktie

 >NEOGEN Aktienkurs 
11.6 EUR    -3.9%    (TradegateBSX)
Ask: 11.555 EUR / 1740 Stück
Bid: 11.49 EUR / 1740 Stück
Tagesumsatz: 2712 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
NEOGEN Aktie über LYNX handeln
>NEOGEN Performance
1 Woche: +1,3%
1 Monat: +19,4%
3 Monate: +44,3%
6 Monate: +58,7%
1 Jahr: +148,9%
laufendes Jahr: +96,2%
>NEOGEN Aktie
Name:  NEOGEN CORP. DL-,16
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US6404911066 / 883297
Symbol/ Ticker:  NG2 (Frankfurt) / NEOG (NASDAQ)
Kürzel:  FRA:NG2, ETR:NG2, NG2:GR, NASDAQ:NEOG
Index:  -
Profil:  Neogen Corp. is a food and animal safety company that develops, manufactures, and markets diagnostic and testing solutions for regulated industries. Its Food Safety segment provides test kits, culture media, and related products used by food and feed..
>Volltext..
Marktkapitalisierung:  2634.57 Mio. EUR
Unternehmenswert:  3171.27 Mio. EUR
Umsatz:  764.07 Mio. EUR
EBITDA:  88.87 Mio. EUR
Nettogewinn:  -6.92 Mio. EUR
Gewinn je Aktie:  -0.03 EUR
Schulden:  712.82 Mio. EUR
Liquide Mittel:  162.84 Mio. EUR
Operativer Cashflow:  73.04 Mio. EUR
Bargeldquote:  1.17
Umsatzwachstum:  -5.32%
Gewinnwachstum:  99.3%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  NEOGEN
Letzte Datenerhebung:  29.09.26
>NEOGEN Kennzahlen
Aktien/ Unternehmen:
Aktien: 218.11 Mio. St.
Frei handelbar: 99.04%
Rückkaufquote: -0.05%
Mitarbeiter: 2636
Umsatz/Mitarb.: 0.29 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: -5.59%
Bewertung:
KGV: -
KGV lG: 44.41
KUV: 3.14
KBV: 1.47
PEG-Ratio: -
EV/EBITDA: 35.68
Rentabilität:
Bruttomarge: 36.38%
Gewinnmarge: -0.91%
Operative Marge: -1.73%
Managementeffizenz:
Gesamtkaprendite: -0.23%
Eigenkaprendite: -0.38%
>NEOGEN Peer Group
Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege, Infektionskrankheiten/ Impfstoffentwicklung/ Antibiotika, Tiermedizin/ Tierbehandlung
 
29.09.26 - 17:15
Neogen gets FDA warning letter over horse deaths linked to Hycoat (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
17.09.26 - 11:00
Biotech Stocks At 52-Week Highs - BlossomHill Therapeutics +18% On Positive Trial Data, Adaptive Biotechnologies, Illumina, CeriBell, Neogen (AFX)
 
SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on September 16, 2026, driven by positive results from clinical trials or an upcoming conference participation.BlossomHill......
15.09.26 - 22:36
Neogen Announces First-Quarter Earnings Release Date (Business Wire)
 
LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG) will issue its first-quarter earnings release after the closing of the market on October 6, 2026. Executives from the company will host a webcast and conference call beginning at 4:30 p.m. Eastern time, to discuss the financial results. The conference call can be accessed by dialing: Toll-Free - North America: 1-833-461-5787 International: (+1) 626-884-3620 Conference ID: 323 558 822 The live webcast can be accessed through Neogen's Investor Relations webpage, neogen.com/investor-relations, under the “Events & Presentations” subheading. A replay of the conference call and webcast will be available shortly following the conclusion of the call and can be accessed by dialing: US Toll: +1 929 828 5978 Toll-Free: +1 833 309 1852 Conference ID: 323 558 822 It will also be available on Neogen's Investor Relations website at neogen.com/investor-relations. About Neogen Neogen Corporation is committed to fueling a brighter future for global ...
10.09.26 - 17:30
Is This the Right Time to Add Neogen Stock to Your Portfolio? (Zacks)
 
NEOG advances product innovation and recovers Animal Safety operations, but high debt and intense competition remain key risks....
31.08.26 - 17:30
Neogen Surges 102.8% in a Year: What′s Driving the Rally? (Zacks)
 
NEOG shares gain 102.8% in a year as R&D investments, Food Safety growth and improving Animal Safety conditions fuel momentum despite key risks....
26.08.26 - 17:06
Neogen upgraded at Piper Sandler on new management (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
26.08.26 - 14:01
Neogen Aktie nach Analysten-Upgrade und Kurszielerhöhung im Aufwind (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
24.08.26 - 19:45
Neogen (NEOG) is a Great Momentum Stock: Should You Buy? (Zacks)
 
Does Neogen (NEOG) have what it takes to be a top stock pick for momentum investors? Let's find out....
11.08.26 - 19:45
Surging Earnings Estimates Signal Upside for Neogen (NEOG) Stock (Zacks)
 
Neogen (NEOG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions....
08.08.26 - 04:36
Neogen (NEOG) Q4 2026 Earnings Call Transcript (Fool)
 
Food Safety segment drives 4.3% core growth as company executes transformation strategy....
06.08.26 - 17:01
Insiderhandel: CEO kauft Aktien von Neogen im Wert von 4370 USD (Insiderkauf)
 
Nassif, Mikheal - Vorstand - Tag der Transaktion: 2026-08-04...
30.07.26 - 19:00
Neogen outlines $880M-$885M FY 2027 revenue and $180M-$182M adjusted EBITDA amid 50% R&D increase (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
30.07.26 - 16:45
Neogen (NEOG) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
 
The headline numbers for Neogen (NEOG) give insight into how the company performed in the quarter ended May 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals....
30.07.26 - 16:00
Neogen (NEOG) Beats Q4 Earnings and Revenue Estimates (Zacks)
 
Neogen (NEOG) delivered earnings and revenue surprises of +80.00% and +6.29%, respectively, for the quarter ended May 2026. Do the numbers hold clues to what lies ahead for the stock?...
30.07.26 - 13:57
Neogen beats top-line and bottom-line estimates; gives Q1 and FY27 outlook (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
30.07.26 - 13:06
Neogen Reports Fourth Quarter and Full Fiscal Year 2026 Financial Results (Business Wire)
 
Delivered Strong Core Growth in Q4 FY26 with Food Safety Core Growth Highest Since FY23 Fiscal fourth quarter 2026 revenue of $225.3 million representing growth of (0.1%) and Core Growth1 of 4.3%; Full fiscal year 2026 revenue of $870.4 million with growth of (2.7%) and Core Growth1 of 1.9% Food Safety fourth quarter revenue growth of 3.1% and Core Growth1 of 5.8%; highest quarterly core growth rate since FY 2023 Animal Safety fourth quarter revenue growth of (8.2%), Core Growth1 of 0.5%; revenue grew 7% sequentially due to resolution of the majority of supply challenges Net loss of $11.3 million in the fourth quarter 2026 with EPS of $(0.05); Adjusted Net Income1 of $18.7 million and Adjusted EPS1 of $0.09 Fourth quarter 2026 cash flow from operations of $30.2 million and free cash flow of $26.2 million Fourth quarter 2026 Adjusted EBITDA1 of $45.4 million; with Adjusted EBITDA1 margin of 20.2% Company on track to manufacture sellable Petrifilm® product and begin planned multi-quarter manufacturing tran...
29.07.26 - 17:06
Neogen Q4 2026 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
20.07.26 - 13:03
Neogen to Release Fourth-Quarter Fiscal Year 2026 Financial Results on July 30, 2026  (Business Wire)
 
LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG) will issue its fourth-quarter earnings release before the opening of the market on Thursday, July 30, 2026. Executives from the company will host a webcast and conference call later that morning, beginning at 8:00 a.m. Eastern time. During the call, Neogen management will provide a financial overview and business update of the company's performance for the fourth-quarter of fiscal year 2026. The conference call can be accessed by dialing: Toll-Free - North America: 1-833-461-5787 International: (+1) 626-884-3620 Conference ID: 741 914 740 The live webcast can also be accessed through Neogen's Investor Relations webpage, neogen.com/investor-relations, under the “Events & Presentations” subheading. A replay of the conference call and webcast will be available shortly following the conclusion of the call and will be available on Neogen's Investor Relations website at neogen.com/investor-relations. About Neogen Neogen Corporation is c...
17.07.26 - 16:42
Zoetis, Neogen deal draws antitrust concerns in Australia (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
26.06.26 - 17:31
Neogen Gains 101.1% in a Year: What′s Driving the Rally? (Zacks)
 
NEOG has surged as Food Safety growth, product launches and 3M integration support higher fiscal 2026 revenue guidance despite cost pressures....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Von all den großen Begrenzungen und Rahmenbedingungen, welche die Poesie und Vielfalt des Lebens bilden und schaffen, ist die entschiedenste und wichtigste die Familie. - Gilbert Keith Chesterton
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!